Pfam Domains GO Terms
| DUF3776 |
| PHD |
| histone acetyltransferase activity (H4-K16 specific) |
| histone acetyltransferase activity (H4-K8 specific) |
| histone acetyltransferase activity (H4-K5 specific) |
| histone H4-K8 acetylation |
| histone H4-K5 acetylation |
| histone H4-K16 acetylation |
| histone acetyltransferase complex |
| MLL1 complex |
| histone H4 acetylation |
| histone acetylation |
| internal peptidyl-lysine acetylation |
| peptidyl-lysine acetylation |
| internal protein amino acid acetylation |
| protein acetylation |
| regulation of signal transduction by p53 class mediator |
| protein acylation |
| nuclear membrane |
| peptidyl-lysine modification |
| histone modification |
| covalent chromatin modification |
| chromatin organization |
| peptidyl-amino acid modification |
| chromosome organization |
| DNA binding |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| regulation of intracellular signal transduction |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| H2AFZ | 0.491 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/25 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/15 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/14 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/7 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution